A 63-year-old man with a history of hepatitis-B-related hepatocellular carcinoma (HCC) in the left lateral portion of the liver received repeated transcatheter arterial chemoembolization (TACE) and salvage radiotherapy. Two months after completing radiotherapy, he presented with dysphagia, epigastric pain, and a protruding abdominal mass. Computed tomography showed that the bulging mass was directly invading the adjacent stomach. Endoscopy revealed a fistula from the HCC invading the stomach. Although the size of the mass had decreased with the drainage through the fistula, and his symptoms had gradually improved, he died of cancer-related bleeding and hepatic failure. This represents a case in which an HCC invaded the stomach and caused a hepatogastric fistula after repeated TACE and salvage radiotherapy. 
INTRODUCTION
Hepatocellular carcinoma (HCC) is the most common primary liver cancer and is now the fifth most common cancer worldwide. 1 In South Korea, HCC is the fourth most common cancer and the third most common cause of cancer-related death. 2 With recent improvements in diagnostic and treatment strategies, survival of patients with HCC had been prolonged significantly. 1 Consequently, the incidence of extrahepatic metastases by HCC is increasing, which currently accounts for 37~64% of all. 1 Of various organs, the lung is the most common site for metastasis, followed by regional lymph nodes and bones. 3 In contrast, metastasis to gastrointestinal (GI) tracts by HCC rarely occurs, being found in only 0.7 to 2% of all HCC patients. [4] [5] [6] Previous case reports proposed that metastasis of HCC mainly occurred through direct invasion, hematogenous spread, or peritoneal seeding. 3, 5, 7 Among them, direct invasion of HCC was known to be the most common route of metastasis to the GI tract. 3, 8, 9 Although most metastases of HCC to the GI tract are incidentally found through imaging study or autopsy because of their asymptomatic presentation, 9, 10 hemorrhage from the GI tract is the most frequent manifestation in case of direct invasion to GI tract by HCC. 7, 11, 12 In this report, we described a case of hepatogastric fistula caused by HCC after repeated transarterial chemoembolization (TACE) and salvage radiotherapy with a review of the literature.
CASE REPORT
A 63-year-old man visited our institute, complaining of dysphagia and postprandial epigastric pain. Physical examination revealed palpable abdominal mass in the epigastric area and laboratory findings were not remarkable except high alkaline phosphatase (118 IU/mL) and bilirubin (1.6 mg/dL) levels. Two months after the end of radiotherapy, we noted that bulging HCC in the left lobe was still directly invading the adjacent stomach ( Fig. 1) . Upper GI endoscopy showed the opening of fistula to HCC which was covered with exudates ( Fig. 2) . Endoscopic biopsy through hepatogastric fistula revealed poorly differentiated HCC (Fig. 3) . His symptoms were thought to be caused by extrinsic compression of the stomach by bulging HCC in the left lobe and we consulted with a surgeon for palliative resection.
However, the resection could not be performed as the patient had poor liver reservoir (indocyanine green retention at 15 minutes [ICG 15], 39.1%). Two weeks later when he re-visited our institute for follow-up, he did not complain about previous symptoms of dysphagia and postprandial epigastric pain. Physical examination showed that the palpable abdominal mass considerably decreased, and CT scans also indicated marked reduced size of the bulging HCC with necrosis in the left lobe (Fig. 4) .
The patient was managed for three months in a conservative 
DISCUSSION
Invasion of the GI tract by HCC is rare and is associated with poor prognosis. Chen et al. reported the first such case which occurred in 2% (8 out of 396 patients) during the course of disease with the median survival of one month (range, two to eight weeks) after the diagnosis. 5 Lin et al. reported that 11 out of 2,237 patients (0.5%) with HCC showed the GI tract involvement, and none of them survived longer than nine months. 13 Although the incidence of hepatogastric fistula in patients with HCC has not yet been reported in South Korea, prognosis after the diagnosis of hepatogastric fistula was grave with survival time of four months in our case.
The sites invaded by HCC were mainly the stomach, duodenum, and colon. Besides two case reports about colonic invasion by HCC 14, 15 and one case report on duodenal invasion HCC, 10 there were a few case reports about gastric invasion by HCC in English language literature from Pubmed, limited to the past 30 years. [7] [8] [9] 11, 16, 17 The mode of metastasis was presumed to be hematogenous or direct invasion by contiguous neoplasm. 3, 5, 11, 13 Although most cases were asymptomatic, hemorrhage was frequent initial manifestation of direct invasion of HCC to the GI tract in previous reports. 7, 11, 12 However, Yo et al indicated that gastric perforation was the initial manifestation of gastric invasion by HCC, not hemorrhage. 16 In our patient, dysphagia and postprandial epigastric pain was the first presentation, and the symptoms disappeared with a sudden shrinkage of the protruding HCC on physical examination and CT scan. It might be attributable to the passage of necrotic materials associated with HCC through hepatogastric fistula. In addition to dysphagia and postprandial epigastric pain, GI tract hemorrhage also developed as a delayed complication four months after the diagnosis of hepatogastric fistula.
HCC invasion of the GI tract can be diagnosed based on radiologic and histologic proofs. Although endoscopic biopsy is still the mainstay method to detect GI tract metastasis in patients with HCC, 13 Park et al suggested that hypervascular GI tract lesion on arterial-phase imaging similar to HCC could be one of the criteria used to document metastatic lesion rather than primary tumor of the GI tract. 3 However, it is sometimes difficult to differentiate metastatic HCC in the GI tract from synchronous stomach cancer. This is particularly true where patients have documented HCC but lack available tumor tissue or have poorly differentiated tissue seen on endoscopic biopsy. 3, 13 In our case, hepatogastric fistula was confirmed by radiologic, endoscopic, and histologic examination.
Since HCC invasion of the GI tract is rare, the exact predispos- HCC invasion of the GI tract is expected to become more common based on the recent increase in the incidence of HCC and more frequent utilization of TACE and radiotherapy to treat unresectable HCC.
